• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于癌症抗缺氧 I 型光动力和免疫治疗的光激活型光热治疗探针。

An Activatable Phototheranostic Probe for Anti-hypoxic Type I Photodynamic- and Immuno-Therapy of Cancer.

机构信息

State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X), Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou, 215123, China.

Department of Imaging, the Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, 213003, China.

出版信息

Adv Mater. 2024 Jan;36(4):e2305243. doi: 10.1002/adma.202305243. Epub 2023 Dec 4.

DOI:10.1002/adma.202305243
PMID:37643544
Abstract

Photodynamic therapy (PDT), which utilizes type I photoreactions, has great potential as an effective cancer treatment because of its hypoxia-tolerant superiority over the commonly used type II pathway. A few type I photosensitizers are exploited; however, they majorly induce cytotoxicity and possess poor tumor specificity and low-efficient theranostics. To resolve this issue, herein an aminopeptidase N (APN)-activated type I phototheranostic probe (CyA) is reported for anti-hypoxic PDT in conjunction with immunotherapy for effective cancer treatment. CyA can specifically activate near-infrared fluorescence, photoacoustic signals, and phototoxicity following APN-induced substrate cleavage and the subsequent generation of active phototheranostic molecules (such as CyBr). CyA endows specific imaging capabilities and effective phototoxicity toward tumor cells overexpressing APN under both normoxia and hypoxia. In addition, the locally activatable PDT induces systemic antitumor immune responses. More importantly, the integration of localized activated PDT and systemic immunotherapy evokes enhanced therapeutic effects with improved tumor inhibition efficiency in live mice compared with individual treatments. This study aims to present an activatable phototheranostic probe for effective hypoxia-tolerant PDT and combination therapy.

摘要

光动力疗法(PDT)利用 I 型光反应,由于其对缺氧的耐受性优于常用的 II 型途径,因此具有作为有效癌症治疗方法的巨大潜力。已经开发了一些 I 型光敏剂;然而,它们主要诱导细胞毒性,并且具有较差的肿瘤特异性和低效率的治疗诊断。为了解决这个问题,本文报道了一种氨肽酶 N(APN)激活的 I 型光热治疗探针(CyA),用于结合免疫疗法进行抗缺氧 PDT,以有效治疗癌症。CyA 可以在 APN 诱导的底物切割和随后产生的活性光治疗分子(如 CyBr)后特异性激活近红外荧光、光声信号和光毒性。CyA 赋予了在常氧和缺氧条件下过表达 APN 的肿瘤细胞特异性成像能力和有效的光毒性。此外,局部激活的 PDT 诱导全身性抗肿瘤免疫反应。更重要的是,与单独治疗相比,局部激活 PDT 和全身免疫治疗的整合在活体小鼠中引发了增强的治疗效果,提高了肿瘤抑制效率。本研究旨在提出一种用于有效耐缺氧 PDT 和联合治疗的可激活光治疗探针。

相似文献

1
An Activatable Phototheranostic Probe for Anti-hypoxic Type I Photodynamic- and Immuno-Therapy of Cancer.一种用于癌症抗缺氧 I 型光动力和免疫治疗的光激活型光热治疗探针。
Adv Mater. 2024 Jan;36(4):e2305243. doi: 10.1002/adma.202305243. Epub 2023 Dec 4.
2
An NIR-II-Emissive Photosensitizer for Hypoxia-Tolerant Photodynamic Theranostics.一种近红外二区发光光敏剂用于耐缺氧光动力治疗。
Adv Mater. 2020 Nov;32(45):e2003471. doi: 10.1002/adma.202003471. Epub 2020 Oct 7.
3
A Dual-Locked Activatable Phototheranostic Probe for Biomarker-Regulated Photodynamic and Photothermal Cancer Therapy.一种双锁激活的光热治疗与光动力治疗两用探针用于标志物调控的光动力和光热癌症治疗。
Angew Chem Int Ed Engl. 2022 Jun 27;61(26):e202202966. doi: 10.1002/anie.202202966. Epub 2022 Apr 27.
4
Targeted co-delivery of a photosensitizer and an antisense oligonucleotide based on an activatable hyaluronic acid nanosystem with endogenous oxygen generation for enhanced photodynamic therapy of hypoxic tumors.基于具有内源性氧生成的活化透明质酸纳米系统的光敏剂和反义寡核苷酸的靶向共递药用于增强缺氧肿瘤的光动力治疗。
Acta Biomater. 2022 Nov;153:419-430. doi: 10.1016/j.actbio.2022.09.025. Epub 2022 Sep 14.
5
Activatable Type I Photosensitizer with Quenched Photosensitization Pre and Post Photodynamic Therapy.具有光动力治疗前和后猝灭光敏化作用的Ⅰ型可激活光动力剂。
Angew Chem Int Ed Engl. 2023 Nov 13;62(46):e202307288. doi: 10.1002/anie.202307288. Epub 2023 Oct 9.
6
Rational design of β-carboline as an efficient type I/II photosensitizer to enable hypoxia-tolerant chemo-photodynamic therapy.理性设计β-咔啉作为高效 I/II 型光敏剂以实现耐缺氧的化学-光动力疗法。
Bioorg Chem. 2023 Dec;141:106875. doi: 10.1016/j.bioorg.2023.106875. Epub 2023 Sep 21.
7
Fibroblast activation protein α activatable theranostic pro-photosensitizer for accurate tumor imaging and highly-specific photodynamic therapy.成纤维细胞激活蛋白 α 激活型治疗前光感剂用于准确的肿瘤成像和高度特异性光动力治疗。
Theranostics. 2022 May 1;12(8):3610-3627. doi: 10.7150/thno.70308. eCollection 2022.
8
GSH and H O Co-Activatable Mitochondria-Targeted Photodynamic Therapy under Normoxia and Hypoxia.在常氧和缺氧条件下,GSH 和 H 2 O 2 共激活的线粒体靶向光动力治疗。
Angew Chem Int Ed Engl. 2020 Jul 13;59(29):12122-12128. doi: 10.1002/anie.202003895. Epub 2020 May 20.
9
Tumor Cell-Responsive Photodynamic Immunoagent for Immunogenicity-Enhanced Orthotopic and Remote Tumor Therapy.肿瘤细胞响应型光动力免疫佐剂增强原位和远处肿瘤治疗的免疫原性。
Adv Healthc Mater. 2023 Feb;12(5):e2202085. doi: 10.1002/adhm.202202085. Epub 2022 Nov 27.
10
An APN-activated NIR photosensitizer for cancer photodynamic therapy and fluorescence imaging.一种用于癌症光动力疗法和荧光成像的 APN 激活近红外光敏剂。
Biomaterials. 2020 Sep;253:120089. doi: 10.1016/j.biomaterials.2020.120089. Epub 2020 May 3.

引用本文的文献

1
Enhanced Cerenkov radiation induced photodynamic therapy based on GSH-responsive biomimetic nanoplatform to trigger immunogenic cell death for tumor immunotherapy.基于谷胱甘肽响应性仿生纳米平台的增强型切伦科夫辐射诱导光动力疗法,以触发免疫原性细胞死亡用于肿瘤免疫治疗。
Asian J Pharm Sci. 2025 Aug;20(4):101070. doi: 10.1016/j.ajps.2025.101070. Epub 2025 May 27.
2
"Dual lock-and-key" triggered and endoplasmic reticulum targeting nanophotosensitizers for activatable Type-I photodynamic and photothermal therapies.用于可激活的I型光动力和光热疗法的“双锁钥”触发及内质网靶向纳米光敏剂
Chem Sci. 2025 Jun 9. doi: 10.1039/d5sc01987g.
3
Multifunctional Organelle-Targeting Probes for Intracellular Imaging and Enhanced Cancer Phototherapy.
用于细胞内成像和增强癌症光疗的多功能细胞器靶向探针。
Chemistry. 2025 Jul 8;31(38):e202500831. doi: 10.1002/chem.202500831. Epub 2025 Jun 18.
4
Amplifying Anti-Tumor Immune Responses via Mitochondria-Targeting Near-Infrared Photodynamic Therapy.通过线粒体靶向近红外光动力疗法增强抗肿瘤免疫反应
Adv Sci (Weinh). 2025 Sep;12(33):e05525. doi: 10.1002/advs.202505525. Epub 2025 Jun 9.
5
Endoplasmic reticulum-targeting activatable nanophotosensitizers for hypoxia relief and enhanced photodynamic therapy.用于缓解缺氧和增强光动力治疗的内质网靶向可激活纳米光敏剂。
Chem Sci. 2025 May 6. doi: 10.1039/d5sc00534e.
6
Improved Orthogonality in Naphthalimide/Cyanine Dyad Boosts Superoxide Generation: a Tumor-Targeted Type-I Photosensitizer for Photodynamic Therapy of Tumor by Inducing Ferroptosis.萘酰亚胺/花菁二元体系中改善的正交性促进超氧阴离子生成:一种通过诱导铁死亡实现肿瘤靶向I型光动力治疗肿瘤的光敏剂
Adv Sci (Weinh). 2025 May;12(17):e2417179. doi: 10.1002/advs.202417179. Epub 2025 Mar 6.
7
RGD peptide-conjugated polydopamine nanoparticles loaded with doxorubicin for combined chemotherapy and photothermal therapy in thyroid cancer.负载阿霉素的RGD肽共轭聚多巴胺纳米颗粒用于甲状腺癌的联合化疗和光热治疗
Discov Oncol. 2024 Dec 18;15(1):794. doi: 10.1007/s12672-024-01682-x.
8
Photodynamic Therapy for Oral Squamous Cell Carcinoma: Current Status, Challenges, and Prospects.光动力疗法治疗口腔鳞状细胞癌:现状、挑战与展望。
Int J Nanomedicine. 2024 Oct 22;19:10699-10710. doi: 10.2147/IJN.S481901. eCollection 2024.
9
A thiol-triggered croconaine-chromene integration to induce ferroptosis and photothermal synergistic efficient tumor ablation.一种硫醇触发的方酸菁-色烯整合以诱导铁死亡和光热协同高效肿瘤消融。
Chem Sci. 2024 Aug 16;15(36):14924-30. doi: 10.1039/d4sc03688c.
10
Wash-Free Bacterial Gram-Typing and Photodynamic Inactivation with Long-Chain-Tailed BODIPY Derivatives.使用长链尾式BODIPY衍生物进行免洗细菌革兰氏分型和光动力灭活
Biomater Res. 2024 Sep 3;28:0069. doi: 10.34133/bmr.0069. eCollection 2024.